Anda di halaman 1dari 1

73360 Federal Register / Vol. 72, No.

247 / Thursday, December 27, 2007 / Notices

The company plans to manufacture Drug Schedule September 23, 1975, (40 FR 43745), all
the listed controlled substances in bulk applicants for registration to import a
for sale to its customers. Oxymorphone (9652) ...... II basic class of any controlled substances
Any other such applicant and any Alfentanil (9737) .............. II in schedule I or II are, and will continue
person who is presently registered with Sufentanil (9740) ............ II to be, required to demonstrate to the
DEA to manufacture such substances Carfentanil (9743) ........... II Deputy Assistant Administrator, Office
may file comments or objections to the Fentanyl (9801) ............... II
of Diversion Control, Drug Enforcement
issuance of the proposed registration Administration, that the requirements
The company plans to bulk
pursuant to 21 CFR 1301.33(a). for such registration pursuant to 21
Any such written comments or manufacture the above listed controlled
substances for sale and distribution to U.S.C. 958(a), 21 U.S.C. 823(a), and 21
objections being sent via regular mail CFR 1301.34(b), (c), (d), (e) and (f) are
should be addressed, in quintuplicate, manufacturers for product development
and formulation. satisfied.
to the Drug Enforcement Administrator, Dated: December 17, 2007.
Any other such applicant and any
Office of Diversion Control, Federal
person who is presently registered with Joseph T. Rannazzisi,
Register Representative (ODL),
DEA to manufacture such substance Deputy Assistant Administrator, Office of
Washington, DC 20537, or any being
may file comments or objections to the Diversion Control, Drug Enforcement
sent via express mail should be sent to Administration.
issuance of the proposed registration
Drug Enforcement Administration,
pursuant to 21 CFR 1301.33(a). [FR Doc. E7–25054 Filed 12–26–07; 8:45 am]
Office of Diversion Control, Federal
Any such written comments or BILLING CODE 4410–09–P
Register Representative (ODL), 8701
objections being sent via regular mail
Morrissette Drive, Springfield, Virginia
should be addressed, in quintuplicate,
22152; and must be filed no later than DEPARTMENT OF JUSTICE
to the Drug Enforcement Administrator,
February 25, 2008.
Office of Diversion Control, Federal
Dated: December 17, 2007. Register Representative (ODL), Drug Enforcement Administration
Joseph T. Rannazzisi, Washington, DC 20537, or any being
Manufacturer of Controlled
Deputy Assistant Administrator, Office of sent via express mail should be sent to
Diversion Control, Drug Enforcement
Substances; Notice of Application
Drug Enforcement Administration,
Administration. Office of Diversion Control, Federal Pursuant to § 1301.33(a) of Title 21 of
[FR Doc. E7–25049 Filed 12–26–07; 8:45 am] Register Representative (ODL), 8701 the Code of Federal Regulations (CFR),
BILLING CODE 4410–09–P Morrissette Drive, Springfield, Virginia this is notice that on November 12,
22152; and must be filed no later than 2007, Orasure Technologies, Inc.,
February 25, 2008. Lehigh University, Seeley G Mudd-
DEPARTMENT OF JUSTICE Building 6, 220 East First Street,
Dated: December 17, 2007.
Joseph T. Rannazzisi,
Bethlehem, Pennsylvania 18015, made
Drug Enforcement Administration application by renewal to the Drug
Deputy Assistant Administrator, Office of
Manufacturer Of Controlled Diversion Control, Drug Enforcement
Enforcement Administration (DEA) as a
Substances; Notice Of Application Administration. bulk manufacturer of the basic classes of
[FR Doc. E7–25045 Filed 12–26–07; 8:45 am]
controlled substances listed in
Pursuant to § 1301.33(a) of Title 21 of schedules I and II:
BILLING CODE 4410–09–P
the Code of Federal Regulations (CFR),
this is notice that on November 6, 2007, Drug Schedule
Noramco Inc., Division of Ortho, DEPARTMENT OF JUSTICE
McNeil, Inc., 500 Swedes Landing Road, Tetrahydrocannabinols I
(THC) (7370).
Wilmington, Delaware 19801, made Drug Enforcement Administration 4–Methoxyamphetamine I
application by renewal to the Drug (7411).
Enforcement Administration (DEA) to Importer of Controlled Substances; Normorphine (9313) ........ I
be registered as a bulk manufacturer of Notice of Application Amphetamine (1100) ...... II
the basic classes of controlled Methamphetamine (1105) II
substances listed in schedules I and II: This is notice that on November 6, Cocaine (9041) ............... II
2007, Noramco Inc., 500 Swedes Oxycodone (9143) .......... II
Drug Schedule Landing Road, Wilmington, Delaware Hydromorphone (9150) ... II
19801, made application by renewal to Benzoylecgonine (9180) II
Codeine-N-oxide (9053) I the Drug Enforcement Administration Hydrocodone (9193) ....... II
Morphine-N-oxide (9307) I (DEA) for registration as an importer of Meperidine (9230) ........... II
Dihydromorphine (9145) II the basic classes of controlled Methadone (9250) .......... II
Codeine (9050) ............... II Morphine (9300) ............. II
substances listed in schedule II:
Dihydrocodeine (9120) ... II
Oxycodone (9143) .......... II The company plans to manufacture
Drug Schedule
Hydromorphone (9150) ... II the listed controlled substances in bulk
Hydrocodone (9193) ....... II Raw Opium (9600) ......... II to manufacture controlled substance
Morphine (9300) ............. II Concentrate of Poppy II derivatives. These derivatives will be
Thebaine (9333) ............. II Straw (9670). used in diagnostic products created
Opium, raw (9600) .......... II specifically for internal use only.
Opium extracts (9610) .... II
mstockstill on PROD1PC66 with NOTICES

The company plans to import the Any other such applicant and any
Opium fluid extract II
(9620). listed controlled substances to person who is presently registered with
Opium tincture (9630) ..... II manufacture other controlled DEA to manufacture such substances
Opium, powdered (9639) II substances. may file comments or objections to the
Opium, granulated (9640) II As noted in a previous notice issuance of the proposed registration
Poppy Staw (9650) ......... II published in the Federal Register on pursuant to 21 CFR 1301.33(a).

VerDate Aug<31>2005 19:40 Dec 26, 2007 Jkt 214001 PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 E:\FR\FM\27DEN1.SGM 27DEN1